The global market for interleukin inhibitors reached USD 20.65 billion in 2022 and is anticipated to reach USD 37.96 billion by 2032, with a projected annual revenue growth rate of 7% during the forecast period. The increasing prevalence of chronic diseases, including diabetes, cancer, and cardiovascular disorders, as reported by the World Health Organization, is […]
